Optimind Pharma Corp. filed its Annual on Jun 28, 2023 for the period ending Feb 28, 2023. In this report its auditor, DNTW Chartered Accountants, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | 0.00% |
Jan. 26 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
Jan. 10 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 358K | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OMND Stock
- News Optimind Pharma Corp.
- Optimind Pharma Corp. Auditor Raises 'Going Concern' Doubt